Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia
作者： Jeffrey J. Molldrem , Peter P. Lee , Changqing Wang , Kyrie Felio , Hagop M. Kantarjian
DOI: 10.1038/79526
关键词: Immune system 、 Medicine 、 Chronic myelogenous leukemia 、 Human cancer 、 Cancer 、 Proteinase 3 、 Immunity 、 Chemotherapy 、 Allogeneic bone marrow transplant 、 Immunology
摘要: Although the immune system has long been implicated in the control of cancer, evidence for specific and efficacious immune responses in human cancer has been lacking. In the case …
nature.com
springer.com
sci-hub.se 参考文章(29)
Stefan Faderl, Moshe Talpaz, Zeev Estrov, Hagop M. Kantarjian, Chronic Myelogenous Leukemia: Biology and Therapy Annals of Internal Medicine. ,vol. 131, pp. 207- 219 ,(1999) , 10.7326/0003-4819-131-3-199908030-00008
C. Dowding, A-P. Guo, D. Maisin, M. Y. Gordon, J. M. Goldman, The effects of interferon‐α on the proliferation of CML progenitor cells in vitro are not related to the precise position of the M‐BCR breakpoint British Journal of Haematology. ,vol. 77, pp. 165- 171 ,(1991) , 10.1111/J.1365-2141.1991.TB07972.X
Elizabeth McLaughlin-Taylor, Hema Pande, Stephen J. Forman, Becky Tanamachi, Cheng-Rong Li, John A. Zaia, Philip D. Greenberg, Stanley R. Riddell, Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytes Journal of Medical Virology. ,vol. 43, pp. 103- 110 ,(1994) , 10.1002/JMV.1890430119
R. Childs, D. Epperson, E. Bahceci, E. Clave, J. Barrett, Molecular remission of chronic myeloid leukaemia following a non-myeloablative allogeneic peripheral blood stem cell transplant: in vivo and in vitro evidence for a graft-versus-leukaemia effect. British Journal of Haematology. ,vol. 107, pp. 396- 400 ,(1999) , 10.1046/J.1365-2141.1999.01706.X
Robert Dengler, Ursula Muunstermann, Salah Al-Batran, Irmela Hausner, Stefan Faderl, Christoph Nerl, Bertold Emmerich, Immunocytochemical and flow cytometric detection of proteinase 3 (myeloblastin) in normal and leukaemic myeloid cells British Journal of Haematology. ,vol. 89, pp. 250- 257 ,(1995) , 10.1111/J.1365-2141.1995.TB03297.X
Joke MM Den Haan, Leslie M Meadows, Wei Wang, Jos Pool, Els Blokland, Tracie L Bishop, Carla Reinhardus, Jeffrey Shabanowitz, Rienk Offringa, Donald F Hunt, Victor H Engelhard, Els Goulmy, The Minor Histocompatibility Antigen HA-1: A Diallelic Gene with a Single Amino Acid Polymorphism Science. ,vol. 279, pp. 1054- 1057 ,(1998) , 10.1126/SCIENCE.279.5353.1054
Dominique Bories, Marie-Cecile Raynal, David H. Solomon, Zbigniew Darzynkiewicz, Yvon E. Cayre, Down-regulation of a serine protease, myeloblastin, causes growth arrest and differentiation of promyelocytic leukemia cells Cell. ,vol. 59, pp. 959- 968 ,(1989) , 10.1016/0092-8674(89)90752-6
Jeffrey J. Molldrem, Changqing Wang, Mark M. Davis, Richard E. Champlin, Peter P. Lee, A PR1-human leukocyte antigen-A2 tetramer can be used to isolate low-frequency cytotoxic T lymphocytes from healthy donors that selectively lyse chronic myelogenous leukemia. Cancer Research. ,vol. 59, pp. 2675- 2681 ,(1999)
Stanley R. Riddell, Philip D. Greenberg, Principles for Adoptive T Cell Therapy of Human Viral Diseases Annual Review of Immunology. ,vol. 13, pp. 545- 586 ,(1995) , 10.1146/ANNUREV.IY.13.040195.002553
Els Goulmy, Ronald Schipper, Jos Pool, Els Blokland, Frederik Falkenburg, Jaak Vossen, Alois Gratwohl, Georgia B. Vogelsang, Hans C. van Houwelingen, Jon J. van Rood, Mismatches of Minor Histocompatibility Antigens between HLA-Identical Donors and Recipients and the Development of Graft-Versus-Host Disease after Bone Marrow Transplantation The New England Journal of Medicine. ,vol. 334, pp. 281- 285 ,(1996) , 10.1056/NEJM199602013340501